hexachlorocyclotriphosphazene: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 220225 |
| CHEMBL ID | 2022081 |
| MeSH ID | M0078885 |
| Synonym |
|---|
| nsc-2667 |
| cyclophosphonitrilic chloride trimer |
| hexachlorocyclotriphosphazene |
| phosphononitrilic chloride trimer |
| 2,4,4,6,6-hexachlorocyclotriphosphazatriene |
| triphosphonitrile chloride |
| cyclophosphazene dichloride trimer |
| 1,5,2,4,6-triazatriphosphorine, 2,2,4,4,6,6-hexachloro-2,2,4,4,6,6-hexahydro- |
| dichlorocyclophosphazine trimer |
| nsc2667 |
| hexachlorocyclophosphazatriene |
| hexachlorophosphazene |
| phosphonitrilic chloride cyclic trimer |
| hexachlorotriphosphonitrile |
| phosphonitrile chloride, cyclic trimer |
| triphosphonitrilic chloride |
| hexachlorocyclotriphosphazatriene |
| phosphonitrilic chloride trimer |
| hexachloro-1,5,2,4,6-triazatriphosphorine |
| 940-71-6 |
| 1,3,5,2,4,6-triazatriphosphorine, 2,2,4,4,6,6-hexachloro-2,2,4,4,6,6-hexahydro- |
| nsc209799 |
| 2,2,4,4,6,6-hexachloro-1,3,5-triaza-2,4,6-triphosphorine |
| 2,2,4,4,6,6-hexachloro-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene |
| nsc-209799 |
| phosphonitrilic chloride trimer, 99.95% trace metals basis |
| phosphonitrilic chloride trimer, 99% |
| cyclic phosphonitrilic chloride trimer |
| AKOS000271204 |
| unii-7vr28mtm9d |
| ai3-24917 |
| nsc 2667 |
| hexachloro-1,3,5,2,4,6-triazatriphosphorine |
| nsc 209799 |
| 7vr28mtm9d , |
| 2,2,4,4,6,6-hexachlorocyclotriphosphazatriene |
| einecs 213-376-8 |
| 2lambda5,4lambda5,6lambda5-1,3,5,2,4,6-triazatriphosphorine, 2,2,4,4,6,6-hexachloro- |
| hexachlorocyclotriphosphazine |
| 25231-98-5 |
| CHEMBL2022081 |
| FT-0602161 |
| hexachlorotriphosphazene |
| 2.lambda.5,4.lambda.5,6.lambda.5-1,3,5,2,4,6-triazatriphosphorine, 2,2,4,4,6,6-hexachloro- |
| hexachlorocyclotriphosphatriazene |
| phosphonitrile chloride, trimer |
| dichlorophosphazene trimer |
| dichlorocyclotriphosphazene |
| phosnic 390 |
| tris(phosphonitrilic chloride) |
| dichlorophosphazene cyclic trimer |
| tris(phosphonitriliic chloride) |
| 2,2,4,4,6,6-hexachloro-2,2,4,4,6,6-hexahydro-1,3,5,2,4,6-triazatriphosphorine |
| 2,2,4,4,6,6-hexachlorocyclotriphosphazene |
| DTXSID4061331 |
| W-100215 |
| phosphonitrilicchloridetrimer |
| 1,3,5,2,4,6-triazatriphosphorine, hexachloro- |
| mfcd00006474 |
| 2,2,4,4,6,6-hexachloro-1,3,5,2lambda~5~,4lambda~5~,6lambda~5~-triazatriphosphinine |
| 2,2,4,4,6,6-hexachloro-1,3,5-triaza-2lambda5,4lambda5,6lambda5-triphosphacyclohexa-1,3,5-triene |
| Q1921671 |
| AMY11104 |
| cyclic phosphonitrilic chloride, trimer |
| 1,3,5,2,4,6-triazatriphosphorine,2,2,4,4,6,6-hexachloro-2,2,4,4,6,6-hexahydro- |
| n3 p3 cl6 |
| 2,2,4,4,6,6-hexachloro-1,3,5,2lambda5,4lambda5-,6lambda5-triazatriphosphinine |
| 2,2,4,4,6,6-hexachloro-2i>>5,4i>>5,6i>>5-cyclotriphosphaza-1,3,5-triene |
| CS-0169388 |
| hexachloro-1,3,5,2lambda5,4lambda5,6lambda5-triazatriphosphinine |
| EN300-7376711 |
| hexachloro-1,3,5,2,4,6-triazatriphosphinine |
Hexachlorocyclotriphosphazene is an old compound which affords very new properties in the field of dendrimers.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Hexachlorocyclotriphosphazene is an old compound which affords very new properties in the field of dendrimers. " | ( The specific functionalization of cyclotriphosphazene for the synthesis of smart dendrimers. Caminade, AM; Hameau, A; Majoral, JP, 2016) | 1.88 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID660102 | Antibacterial activity against Escherichia coli ATCC 35218 after 18 to 24 hrs by broth microdilution method | 2012 | European journal of medicinal chemistry, Jun, Volume: 52 | Synthesis, cytotoxicity and apoptosis of cyclotriphosphazene compounds as anti-cancer agents. |
| AID660090 | Cytotoxicity against human HT-29 cells after 24 hrs at 37 degC by MTT assay | 2012 | European journal of medicinal chemistry, Jun, Volume: 52 | Synthesis, cytotoxicity and apoptosis of cyclotriphosphazene compounds as anti-cancer agents. |
| AID660101 | Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by broth microdilution method | 2012 | European journal of medicinal chemistry, Jun, Volume: 52 | Synthesis, cytotoxicity and apoptosis of cyclotriphosphazene compounds as anti-cancer agents. |
| AID660092 | Cytotoxicity against african green monkey Vero cells after 24 hrs at 37 degC by MTT assay | 2012 | European journal of medicinal chemistry, Jun, Volume: 52 | Synthesis, cytotoxicity and apoptosis of cyclotriphosphazene compounds as anti-cancer agents. |
| AID660104 | Antifungal activity against Candida albicans ATCC 10231 after 48 hrs by broth microdilution method | 2012 | European journal of medicinal chemistry, Jun, Volume: 52 | Synthesis, cytotoxicity and apoptosis of cyclotriphosphazene compounds as anti-cancer agents. |
| AID660093 | Induction of apoptosis in human HT-29 cells assessed as viable cell level after 24 hrs by annexin V-FITC and propidium iodide staining based flow cytometry | 2012 | European journal of medicinal chemistry, Jun, Volume: 52 | Synthesis, cytotoxicity and apoptosis of cyclotriphosphazene compounds as anti-cancer agents. |
| AID660096 | Induction of apoptosis in human HT-29 cells assessed as necrotic cells level after 24 hrs by annexin V-FITC and propidium iodide staining based flow cytometry | 2012 | European journal of medicinal chemistry, Jun, Volume: 52 | Synthesis, cytotoxicity and apoptosis of cyclotriphosphazene compounds as anti-cancer agents. |
| AID660103 | Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by broth microdilution method | 2012 | European journal of medicinal chemistry, Jun, Volume: 52 | Synthesis, cytotoxicity and apoptosis of cyclotriphosphazene compounds as anti-cancer agents. |
| AID660091 | Cytotoxicity against human Hep2 cells after 24 hrs at 37 degC by MTT assay | 2012 | European journal of medicinal chemistry, Jun, Volume: 52 | Synthesis, cytotoxicity and apoptosis of cyclotriphosphazene compounds as anti-cancer agents. |
| AID660094 | Induction of apoptosis in human HT-29 cells assessed as early apoptotic cells level after 24 hrs by annexin V-FITC and propidium iodide staining based flow cytometry | 2012 | European journal of medicinal chemistry, Jun, Volume: 52 | Synthesis, cytotoxicity and apoptosis of cyclotriphosphazene compounds as anti-cancer agents. |
| AID660095 | Induction of apoptosis in human HT-29 cells assessed as late apoptotic cells level after 24 hrs by annexin V-FITC and propidium iodide staining based flow cytometry | 2012 | European journal of medicinal chemistry, Jun, Volume: 52 | Synthesis, cytotoxicity and apoptosis of cyclotriphosphazene compounds as anti-cancer agents. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (34.84) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (7.69%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 12 (92.31%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||